{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-409819","form_type":"8-K","ticker":"KYNB","cik":"0000921299","company_name":"KYNTRA BIO, INC.","filed_at":"2026-10-01T11:30:19+00:00","discovered_at":"2026-10-01T11:35:11.598996+00:00","generated_at":"2026-10-12T14:14:58.924935+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Kyntra Bio appoints Andrew Singer to board, Maykin Ho resigns; CEO Wettig signs new severance agreement","bullets":["Andrew E. Singer, MBA was appointed as a Class III director and Audit Committee member effective October 1, 2026; his term expires in 2029.","Maykin Ho, Ph.D. resigned from the board effective September 30, 2026 after serving since December 2018, including on the Audit Committee; no disagreement cited.","CEO Thane Wettig entered a new Change in Control and Severance Agreement on September 30, 2026, with a three-year term ending October 2, 2029; no material changes to pay.","Singer has 25+ years in biotech finance, led West Coast biotech investment banking at Credit Suisse, was Epizyme CFO, and advised on over $50 billion in transactions.","Kyntra Bio common stock trades on Nasdaq under KYNB; it focuses on oncology and rare disease therapies."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-409819","json":"https://secwatch.observer/filing/0001193125-26-409819.json","markdown":"https://secwatch.observer/filing/0001193125-26-409819.md","text":"https://secwatch.observer/filing/0001193125-26-409819.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921299/000119312526409819/0001193125-26-409819-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921299/000119312526409819/kynb-20260930.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:14:58.924935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}